
Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment
Keywords: Piperacillin; Tazobactam; Peritonitis; Inflammatory bowel disease; Pharmacokinetics; Pharmacodynamics; PIP-TAZ; piperacillin-tazobactam; AUC; area under the drug concentration-time curve; MIC; minimum inhibitory concentration; Cmax; observed maximum conce